![Anna Berkenblit](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anna Berkenblit
Directeur/Bestuurslid bij
SURROZEN, INC.
Vermogen: 61 358 $ op 31-05-2026
Profiel
Anna Berkenblit currently serves as Director at Surrozen Operating, Inc. since 2019, Independent Director at Surrozen, Inc. since 2018, Director at Nested Therapeutics, Inc., and Chief Scientific & Medical Officer at Pancreatic Cancer Action Network, Inc. Former roles include Chief Medical Officer & Senior Vice President at ImmunoGen, Inc. from 2019 to 2023, Vice President at Pfizer Inc. from 2007 to 2011, Vice President & Head-Clinical Research at AVEO Pharmaceuticals, Inc. from 2011 to 2013, and Senior Vice President-Clinical Development at H3 Biomedicine, Inc. from 2013 to 2015.
Education includes graduate degrees from Harvard University and Massachusetts Institute of Technology, an undergraduate degree from Yale University, and a doctorate from Harvard Medical School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SURROZEN INC 0,02% | 13-05-2026 | 2.341 ( 0,02% ) | 61 358 $ | 31-05-2026 |
Actieve functies van Anna Berkenblit
| Bedrijven | Functie | Begin |
|---|---|---|
| SURROZEN, INC. | Directeur/Bestuurslid | 01-08-2018 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Directeur/Bestuurslid | 14-03-2019 |
Nested Therapeutics, Inc.
 Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Directeur/Bestuurslid | - |
Pancreatic Cancer Action Network, Inc.
 Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Anna Berkenblit
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 31-08-2023 |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Corporate Officer/Principal | 01-01-2015 |
| AVEO PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 |
| PFIZER INC. | Corporate Officer/Principal | 01-09-2011 |
Opleiding van Anna Berkenblit
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
67
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of genomic drugs | Commercial Services |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery biotechnology company | Commercial Services |
